| Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. AR Glabinski, V Balasingam, M Tani, SL Kunkel, RM Strieter, VW Yong, ... Journal of immunology (Baltimore, Md.: 1950) 156 (11), 4363-4368, 1996 | 363 | 1996 |
| Synchronous synthesis of alpha-and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune … AR Glabinski, M Tani, RM Strieter, VK Tuohy, RM Ransohoff The American journal of pathology 150 (2), 617, 1997 | 332 | 1997 |
| Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. DR Huang, Y Han, MR Rani, A Glabinski, C Trebst, T Sorensen, M Tani, ... Immunological reviews 177 (1), 2000 | 291 | 2000 |
| Chemokines and chemokine receptors in CNS pathology AR Glabinski, RM Ransohoff Journal of neurovirology 5 (1), 3-12, 1999 | 211 | 1999 |
| Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I K Selmaj, W Papierz, A Glabinski, T Kohno Journal of neuroimmunology 56 (2), 135-141, 1995 | 209 | 1995 |
| Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis AR Glabinski, M Tani, VK Tuohy, RJ Tuthill, RM Ransohoff Brain, behavior, and immunity 9 (4), 315-330, 1995 | 187 | 1995 |
| Chemokines in immune-mediated inflammation of the central nervous system RM Ransohoff, A Glabinski, M Tani Cytokine & growth factor reviews 7 (1), 35-46, 1996 | 173 | 1996 |
| In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. M Tani, AR Glabinski, VK Tuohy, MH Stoler, ML Estes, RM Ransohoff The American journal of pathology 148 (3), 889, 1996 | 147 | 1996 |
| Expression of chemokines RANTES, MIP-1α and GRO-α correlates with inflammation in acute experimental autoimmune encephalomyelitis AR Glabinski, VK Tuohy, RM Ransohoff Neuroimmunomodulation 5 (3-4), 166-171, 1998 | 134 | 1998 |
| Neurofilament ELISA validation A Petzold, A Altintas, L Andreoni, A Bartos, A Berthele, MA Blankenstein, ... Journal of immunological methods 352 (1-2), 23-31, 2010 | 109 | 2010 |
| Regulation and function of central nervous system chemokines AR Glabinski, M Tani, S Aras, MH Stoler, VK Tuohy, RM Ransohoff International journal of developmental neuroscience 13 (3-4), 153-165, 1995 | 98 | 1995 |
| Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis AR Glabinski, M Krakowski, Y Han, T Owens, RM Ransohoff Journal of neurovirology 5 (1), 95-101, 1999 | 95 | 1999 |
| Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis DW Wojkowska, P Szpakowski, D Ksiazek-Winiarek, M Leszczynski, ... Mediators of inflammation 2014, 2014 | 94 | 2014 |
| Neural plasticity in multiple sclerosis: the functional and molecular background DJ Ksiazek-Winiarek, P Szpakowski, A Glabinski Neural plasticity 2015, 2015 | 83 | 2015 |
| Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis AR Glabinski, B Bielecki, RM Ransohoff Scandinavian journal of immunology 58 (1), 81-88, 2003 | 77 | 2003 |
| Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma D Grzybicki, SA Moore, R Schelper, AR Glabinski, RM Ransohoff, ... Acta neuropathologica 95, 98-103, 1997 | 75 | 1997 |
| Interleukin 17A promotes lymphocytes adhesion and induces CCL2 and CXCL1 release from brain endothelial cells DW Wojkowska, P Szpakowski, A Glabinski International journal of molecular sciences 18 (5), 1000, 2017 | 70 | 2017 |
| MicroRNAs as novel regulators of neuroinflammation DJ Ksiazek-Winiarek, MJ Kacperska, A Glabinski Mediators of inflammation 2013, 2013 | 66 | 2013 |
| Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type … VA Folcik, T Smith, S O'Bryant, JA Kawczak, B Zhu, H Sakurai, A Kajiwara, ... Journal of neuroimmunology 97 (1-2), 119-128, 1999 | 65 | 1999 |
| The presence of caffeic acid in cerebrospinal fluid: Evidence that dietary polyphenols can cross the blood-brain barrier in humans I Grabska-Kobylecka, J Kaczmarek-Bak, M Figlus, A Prymont-Przyminska, ... Nutrients 12 (5), 1531, 2020 | 54 | 2020 |
